AAAAAA

   
Results: 1-7 |
Results: 7
WORKSHOP II - EFFICACY, SAFETY AND TREATMENT COST CONSIDERATIONS
Authors: LUSHER J GIANGRANDE PLF EWENSTEIN B LEE CA INWOOD MJ
Citation: J. Lusher et al., WORKSHOP II - EFFICACY, SAFETY AND TREATMENT COST CONSIDERATIONS, Haemophilia, 3, 1997, pp. 12-23
A MULTICENTER STUDY OF RECOMBINANT FACTOR-VIII (RECOMBINATE(TM)) IN PREVIOUSLY TREATED PATIENTS WITH HEMOPHILIA-A
Authors: WHITE GC COURTER S BRAY GL LEE M GOMPERTS ED WHITE G COOPER H HAIRE W BRETTLER D KISKER T HOOTS K SHAPIRO A HALIE MR MANNUCCI PM SCHARRER I BRACKMANN HH GORDON EM GOLDSMITH J HILGARTNER M GILL J LAURIAN Y LARRIEU Y KESSLER C PAI MKR LUSHER JM NEUFELD E EWENSTEIN B SCHULMAN S MORFINI M ADDIEGO JE VERMYLEN JG KRILL CE INGERSLEV J
Citation: Gc. White et al., A MULTICENTER STUDY OF RECOMBINANT FACTOR-VIII (RECOMBINATE(TM)) IN PREVIOUSLY TREATED PATIENTS WITH HEMOPHILIA-A, Thrombosis and haemostasis, 77(4), 1997, pp. 660-667
WARFARIN THERAPY IN CANCER-PATIENTS WITH VENOUS THROMBOEMBOLIC DISEASE (VTD)
Authors: MARTINS RG COLOWICK AB STARK P KUTER DJ EWENSTEIN B
Citation: Rg. Martins et al., WARFARIN THERAPY IN CANCER-PATIENTS WITH VENOUS THROMBOEMBOLIC DISEASE (VTD), Blood, 90(10), 1997, pp. 1313-1313
HEPATITIS-A AMONG PERSONS WITH HEMOPHILIA WHO RECEIVED CLOTTING FACTOR CONCENTRATE - UNITED-STATES, SEPTEMBER-DECEMBER 1995 (REPRINTED FROMMMWR, VOL 45, PG 29-32, 1996)
Authors: RUYMANN FB KRILL CE HALPIN TJ CHURCHILL WH EWENSTEIN B DEMARIA A MANCOJOHNSON MJ HOFFMAN RE
Citation: Fb. Ruymann et al., HEPATITIS-A AMONG PERSONS WITH HEMOPHILIA WHO RECEIVED CLOTTING FACTOR CONCENTRATE - UNITED-STATES, SEPTEMBER-DECEMBER 1995 (REPRINTED FROMMMWR, VOL 45, PG 29-32, 1996), JAMA, the journal of the American Medical Association, 275(6), 1996, pp. 427-428
TRANSFUSION AND CYTOMEGALOVIRUS-ASSOCIATED AIDS-DEFINING DISEASE IN HEMOPHILIACS
Authors: RAGNI MV TRIULZI DJ BASS D DUERSTEIN S BRETTLER DB FORAND P EWENSTEIN B MCGREAL C ALEDORT LM MCCARTHY J HILGARTNER MW KLEINERT D RAGNI MV KRATOFIL M BARRON LE HAMS A WHITE GC NIELSEN B GILL JC SCHALL MA GREEN D HARRIS S BUCHANAN GR RUTHERFORD C MILLER K LAUFENBERG J DUNNAGAN T SWINDELLS S HANLON E STABLER SP GIAMBARTOLOMEI S SMITH KJ SCHWARTZ M SANDERS NL ADIEGGO JE CHASE B LOVRIEN EW INGRAMRICH R
Citation: Mv. Ragni et al., TRANSFUSION AND CYTOMEGALOVIRUS-ASSOCIATED AIDS-DEFINING DISEASE IN HEMOPHILIACS, Transfusion, 36(8), 1996, pp. 681-684
HYDROXYUREA CHANGES SS RBC BIOCHEMICAL BIOPHYSICAL PROFILE TO THAT OFSC RBCS
Authors: BRIDGES K BARABINO G BRUGNARA C CHRISTOPH G CHO M DOVER G EATON W EWENSTEIN B GOLAN D GUTTMANN C HOFRICHTER J MULKERN R ZHANG B
Citation: K. Bridges et al., HYDROXYUREA CHANGES SS RBC BIOCHEMICAL BIOPHYSICAL PROFILE TO THAT OFSC RBCS, Blood, 84(10), 1994, pp. 10000413-10000413
A MULTICENTER STUDY OF RECOMBINANT FACTOR-VIII (RECOMBINATE) - SAFETY, EFFICACY, AND INHIBITOR RISK IN PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A
Authors: BRAY GL GOMPERTS ED COURTER S GRUPPO R GORDON EM MANCOJOHNSON M SHAPIRO A SCHEIBEL E WHITE G LEE M GORDON M BERTALONE S LIPTON R HILGARTNER M ARKIN S GILL J KIM H SHURIN S SANTIAGOBORRERO P ARKEL YS KULKARNI R GREENWOOD MF RITCHEY AK WERNER E HAIRE WD KISKER T NEUFELD E EWENSTEIN B DEBIASI R LAURIAN Y KREUZ W RODEGHIERO F INGERSLEV J GAZENGEL C DIMICHELE D COOPER H
Citation: Gl. Bray et al., A MULTICENTER STUDY OF RECOMBINANT FACTOR-VIII (RECOMBINATE) - SAFETY, EFFICACY, AND INHIBITOR RISK IN PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A, Blood, 83(9), 1994, pp. 2428-2435
Risultati: 1-7 |